Moderna Procures Machine Learning Partnership to Boost Generative AI Use In Drug Discovery
![](https://www.mcalindenresearchpartners.com/wp-content/uploads/2024/04/google-deepmind-8heReYC6Zt0-unsplash-1024x576.jpg)
Moderna has announced a partnership between itself and OpenAI, allowing the biopharma firm to utilize the latter's enterprise ChatGPT product…
McAlinden Research PartnersApril 25, 2024